RBCL Stock Overview

Manufactures, markets, and distributes nutritional supplements and personal care products in North America, Southeast Asia, and Australia. More details

RBCL fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Latest financial reports are more than a year old

Shares are highly illiquid

High level of non-cash earnings

Does not have a meaningful market cap ($3K)

My Notes

Capture your thoughts, links and company narrative

RBC Life Sciences, Inc. Competitors

LifeQuest World

OTCPK:LQWC

US$1.2m

Nevis Brands

OTCPK:NEVI.F

US$2.1m

Shineco

NasdaqCM:SISI

US$19.6m

Cyanotech

OTCPK:CYAN

US$2.6m

Price History & Performance

Summary of share price highs, lows and changes for RBC Life Sciences
Historical stock prices
Current Share Price	US$0.000067
52 Week High	US$0.0003
52 Week Low	US$0.000067
Beta	0
1 Month Change	0%
3 Month Change	n/a
1 Year Change	-66.50%
3 Year Change	-99.95%
5 Year Change	-99.89%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	RBCL	US Personal Products	US Market
7D	0%	2.3%	-0.4%
1Y	-66.5%	-29.4%	20.8%

Return vs Industry: RBCL underperformed the US Personal Products industry which returned -28.8% over the past year.

Return vs Market: RBCL underperformed the US Market which returned 22% over the past year.

Price Volatility

Is RBCL's price volatile compared to industry and market?
RBCL volatility
RBCL Average Weekly Movement	n/a
Personal Products Industry Average Movement	7.8%
Market Average Movement	6.0%
10% most volatile stocks in US Market	18.0%
10% least volatile stocks in US Market	3.1%

Stable Share Price: RBCL has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine RBCL's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1988	n/a	David Price	www.rbclifesciences.com

RBC Life Sciences, Inc. manufactures, markets, and distributes nutritional supplements and personal care products in North America, Southeast Asia, and Australia. The company’s Nutritional Products segment offers nutritional supplements and personal care products, including herbs, vitamins, and minerals; and natural skin, hair, and body care products through a network of independent distributors and license arrangements. Its products include Stem-Kine, a dietary supplement; Microhydrin and Microhydrin Plus antioxidants; VitAloe, a blend of research-backed ingredients; OliViva, an antioxidant beverage to support immune and cardiovascular system; Organic Spirulina, a nutritious alga that provides range of nutrients and easily digested proteins; and NeuroBright to support brain function, and enhance energy and acuity.

RBC Life Sciences, Inc. Fundamentals Summary

How do RBC Life Sciences's earnings and revenue compare to its market cap?
RBCL fundamental statistics
Market cap	US$2.83k
Earnings (TTM)	-US$559.51k
Revenue (TTM)	US$24.12m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is RBCL overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RBCL income statement (TTM)
Revenue	US$24.12m
Cost of Revenue	US$10.39m
Gross Profit	US$13.72m
Other Expenses	US$14.28m
Earnings	-US$559.51k

Last Reported Earnings

Sep 30, 2015

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did RBCL perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/07/16 10:23
End of Day Share Price	2024/04/18 00:00
Earnings	2015/09/30
Annual Earnings	2014/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

RBC Life Sciences, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.